Related Articles
Molecular biomarkers and integrated pathological diagnosis in the reclassification of gliomas
Altered capicua transcriptional repressor gene expression exhibits distinct prognostic value for isocitrate dehydrogenase-mutant oligodendroglial tumors
SRSF1 induces glioma progression and has a potential diagnostic application in grading primary glioma
IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy
IDH1 mutation of gliomas with long-term survival analysis